191 related articles for article (PubMed ID: 9857466)
1. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
[TBL] [Abstract][Full Text] [Related]
2. [Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi-institutional study].
Kitamura M; Koyanagi H; Kawada S; Hosoda Y; Kurosawa H; Takeuchi Y; Kawase M; Wanibuchi Y
Kyobu Geka; 1999 Nov; 52(12):1001-4. PubMed ID: 10554485
[TBL] [Abstract][Full Text] [Related]
3. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW
J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143
[No Abstract] [Full Text] [Related]
4. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
[TBL] [Abstract][Full Text] [Related]
5. Reduction of mechanical heart valve thrombosis through a clinical audit.
Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
[TBL] [Abstract][Full Text] [Related]
7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
8. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
9. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
Bruhn HD; Zurborn KH
J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
[TBL] [Abstract][Full Text] [Related]
10. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement.
Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R
Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283
[TBL] [Abstract][Full Text] [Related]
11. [Insufficient anticoagulation after mitral valve replacement. Valve (almost) occluded, patient saved at the last minute].
Stiefelhagen P
MMW Fortschr Med; 2005 Sep; 147(37):13-4. PubMed ID: 16193869
[No Abstract] [Full Text] [Related]
12. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
[TBL] [Abstract][Full Text] [Related]
13. [Intensity of oral anticoagulant therapy after heart valve replacement].
Stenzinger W
Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
[TBL] [Abstract][Full Text] [Related]
14. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
[TBL] [Abstract][Full Text] [Related]
15. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation in patients with heart valve replacement in pregnancy].
Harenberg J
Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
[TBL] [Abstract][Full Text] [Related]
17. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-.
Mori T; Asano M; Ohtake H; Bitoh A; Sekiguchi S; Matsuo Y; Aiba M; Yamada M; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):83-7. PubMed ID: 12027793
[TBL] [Abstract][Full Text] [Related]
19. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
20. North American multicenter experience with the On-X prosthetic heart valve.
McNicholas KW; Ivey TD; Metras J; Szentpetery S; Marra SW; Masters RG; Dilling EW; Slaughter MS; Mack MJ
J Heart Valve Dis; 2006 Jan; 15(1):73-8; discussion 79. PubMed ID: 16480015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
